Partnership
Kakao Healthcare inks MoU with Novo Nordisk Pharma
The partnership integrates blood sugar management service with Novo Nordisk’s ‘Malia Smart Sensor’ for enhanced patient care. Read More>>
Centre Setup and Expansion
Moderna opens a research hub in Melbourne
The center will collaborate with local institutes and is accompanied by a nearby mRNA manufacturing facility set to produce 100 million vaccine doses annually. Read More>>
Astellas to expand presence in Massachusetts with new research hub
Astellas is expanding in Cambridge with a life sciences facility spanning 62,000 square feet by 2024. The hub will house offices, labs, and the Discovery Accelerator startup initiative. Read More>>
Merger and Acquisition
Novo Nordisk has acquired InversagoNovo
Novo Nordisk acquires Inversago Pharma for a potential $1 billion deal, gaining INV-202, an oral CB1 inverse agonist for metabolic diseases like obesity and diabetes. Read More>>
Executive Movement
Hikma announces Dr. Bill Larkins as President of injectables business
Dr. Larkins brings extensive expertise in the sterile injectable generic market, having served as CEO of Custopharm and held leadership roles in prominent pharmaceutical firms. Read More>>
Layoff
Biogen is laying off 11% of its workforce
Biogen is cutting 1,000 employees, with initial cuts taking place in Cambridge. The layoffs are due to the challenges faced by some of the company’s products. Read More>>
Product Launch
Upsher-Smith Labs has launched Famotidine for Oral Suspension, USP
Upsher-Smith Labs has launched Famotidine for Oral Suspension, USP, in partnership with Appco Pharma. The product is a generic version of Pepcid® for oral suspension. Read More>>
|